{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:13:30Z","timestamp":1790802810420,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":3136,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1038\/sj.jidsymp.5650031","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T15:44:48Z","timestamp":1179157488000},"page":"16-21","source":"Crossref","is-referenced-by-count":51,"title":["Reactivation of Latent Tuberculosis by TNF Blockade: The Role of Interferon \u03b3"],"prefix":"10.1016","volume":"12","author":[{"given":"Robert S.","family":"Wallis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.jidsymp.5650031_bb0010","series-title":"Enbrel Prescribing Information","author":"Amgen and Wyeth Pharmaceuticals","year":"2005"},{"key":"10.1038\/sj.jidsymp.5650031_bb0015","series-title":"Humira Prescribing Information","author":"Abbott Laboratories","year":"2005"},{"key":"10.1038\/sj.jidsymp.5650031_bb0020","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.4049\/jimmunol.160.12.6072","article-title":"Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms","volume":"160","author":"Allendoerfer","year":"1998","journal-title":"J Immunol"},{"key":"10.1038\/sj.jidsymp.5650031_bb0025","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"10.1038\/sj.jidsymp.5650031_bb0030","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/art.20454","article-title":"Increased risk of coccidioidomycosis in patients treated with TNF antagonists","volume":"50","author":"Bergstrom","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/sj.jidsymp.5650031_bb0035","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/1521-4141(200106)31:6<1935::AID-IMMU1935>3.0.CO;2-N","article-title":"Differential effects of TNF and LTalpha in the host defense against M. bovis BCG","volume":"31","author":"Bopst","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1038\/sj.jidsymp.5650031_bb0040","first-page":"1532","article-title":"Antirheumatic drugs and the risk of tuberculosis","volume":"43","author":"Brassard","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1038\/sj.jidsymp.5650031_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","article-title":"Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis","volume":"2","author":"Brennan","year":"1989","journal-title":"Lancet"},{"key":"10.1038\/sj.jidsymp.5650031_bb0050","series-title":"Reported Tuberculosis in the United States, 2000","author":"CDC","year":"2001"},{"key":"10.1038\/sj.jidsymp.5650031_bb0055","first-page":"901","article-title":"Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis","volume":"9","author":"Cheon","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1038\/sj.jidsymp.5650031_bb0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/gut.53.1.70","article-title":"Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease","volume":"53","author":"Di Sabatino","year":"2004","journal-title":"Gut"},{"key":"10.1038\/sj.jidsymp.5650031_bb0065","doi-asserted-by":"crossref","first-page":"17595","DOI":"10.1016\/S0021-9258(18)71533-0","article-title":"The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding","volume":"264","author":"Eck","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.jidsymp.5650031_bb0070","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1038\/sj.jidsymp.5650031_bb0075","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/eji.1830250841","article-title":"Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections","volume":"25","author":"Garcia","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1038\/sj.jidsymp.5650031_bb0080","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/eji.1830271215","article-title":"High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas","volume":"27","author":"Garcia","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1038\/sj.jidsymp.5650031_bb0085","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1073\/pnas.93.8.3193","article-title":"Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production","volume":"93","author":"Hirsch","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.jidsymp.5650031_bb0090","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1086\/315114","article-title":"Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy","volume":"180","author":"Hirsch","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1038\/sj.jidsymp.5650031_bb0095","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1086\/344359","article-title":"Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity","volume":"186","author":"Hoft","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1038\/sj.jidsymp.5650031_bb0100","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/IAI.73.5.2595-2601.2005","article-title":"Survival and replication of clinical Mycobacterium tuberculosis isolates in the context of human innate immunity","volume":"73","author":"Janulionis","year":"2005","journal-title":"Infect Immun"},{"key":"10.1038\/sj.jidsymp.5650031_bb0105","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","article-title":"Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection","volume":"335","author":"Jouanguy","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.jidsymp.5650031_bb0110","first-page":"23","article-title":"Generation of nitric oxide and clearance of interferon-gamma after BCG infection are impaired in mice that lack the interferon-gamma receptor","volume":"46","author":"Kamijo","year":"1995","journal-title":"J Inflamm"},{"key":"10.1038\/sj.jidsymp.5650031_bb0115","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/315766","article-title":"Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria","volume":"182","author":"Kampmann","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1038\/sj.jidsymp.5650031_bb0120","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1128\/IAI.72.11.6401-6407.2004","article-title":"A novel human in vitro system to evaluate antimycobacterial vaccines","volume":"72","author":"Kampmann","year":"2004","journal-title":"Infect Immun"},{"key":"10.1038\/sj.jidsymp.5650031_bb0125","first-page":"379","article-title":"Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice","volume":"79","author":"Kaneko","year":"1999","journal-title":"Lab Invest"},{"key":"10.1038\/sj.jidsymp.5650031_bb0130","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.jidsymp.5650031_bb0135","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(89)90676-4","article-title":"The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection","volume":"56","author":"Kindler","year":"1989","journal-title":"Cell"},{"key":"10.1038\/sj.jidsymp.5650031_bb0140","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/art.10583","article-title":"Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept","volume":"46","author":"Lee","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1038\/sj.jidsymp.5650031_bb0145","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1073\/pnas.091096998","article-title":"Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha\/beta","volume":"98","author":"Manca","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.jidsymp.5650031_bb0150","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1086\/320725","article-title":"Macrophage-activating cytokines in human immununodeficiency virus type 1-infected and -uninfected patients with pulmonary tuberculosis","volume":"183","author":"Mayanja-Kizza","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1038\/sj.jidsymp.5650031_bb0155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2004.11.060","article-title":"Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha","volume":"128","author":"Mitoma","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1038\/sj.jidsymp.5650031_bb0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semarthrit.2005.01.004","article-title":"Clinical pharmacokinetics of TNF antagonists: how do they differ?","volume":"34","author":"Nestorov","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1038\/sj.jidsymp.5650031_bb0165","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.160.2.943","article-title":"TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation","volume":"160","author":"Peschon","year":"1998","journal-title":"J Immunol"},{"key":"10.1038\/sj.jidsymp.5650031_bb0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/00313029009063555","article-title":"Lymphocyte subsets in granulomas of human tuberculosis: an in situ immunofluorescence study using monoclonal antibodies","volume":"22","author":"Randhawa","year":"1990","journal-title":"Pathology"},{"key":"10.1038\/sj.jidsymp.5650031_bb0175","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00054725-200411000-00015","article-title":"Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease","volume":"10","author":"Ringheanu","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1038\/sj.jidsymp.5650031_bb0180","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","article-title":"TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection","volume":"168","author":"Roach","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/sj.jidsymp.5650031_bb0185","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/nar\/25.3.680","article-title":"An ELISA for detection of apoptosis","volume":"25","author":"Salgame","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/sj.jidsymp.5650031_bb0190","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1086\/505430","article-title":"Tumor necrosis factor blockers: differential effects on mycobacterial immunity","volume":"194","author":"Saliu","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1038\/sj.jidsymp.5650031_bb0195","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1038\/sj.jidsymp.5650031_bb0200","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/sj.jidsymp.5650031_bb0205","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/ard.2005.043166","article-title":"Safety analyses of adalimumab (HUMIRA(R)) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis","volume":"65","author":"Schiff","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/sj.jidsymp.5650031_bb0210","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4049\/jimmunol.155.3.1489","article-title":"Intercellular adhesion molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by IL-10 and IL-6","volume":"155","author":"Shrikant","year":"1995","journal-title":"J Immunol"},{"key":"10.1038\/sj.jidsymp.5650031_bb0215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.10758","article-title":"Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents","volume":"48","author":"Slifman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1038\/sj.jidsymp.5650031_bb0220","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.10302","article-title":"The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial","volume":"46","author":"St Clair","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1038\/sj.jidsymp.5650031_bb0225","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1086\/374799","article-title":"Failure to control growth of mycobacteria in blood from children infected with human immunodeficiency virus, and its relationship to T cell function","volume":"187","author":"Tena","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1038\/sj.jidsymp.5650031_bb0230","first-page":"1561","article-title":"Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab","volume":"29","author":"True","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1038\/sj.jidsymp.5650031_bb0235","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease","volume":"124","author":"Van den Brande","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1038\/sj.jidsymp.5650031_bb0240","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1086\/429996","article-title":"Reactivation of latent granulomatous infections by infliximab","volume":"41","author":"Wallis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1038\/sj.jidsymp.5650031_bb0245","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/424455","article-title":"Granulomatous infections due to tumor necrosis factor blockade: correction","volume":"39","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1038\/sj.jidsymp.5650031_bb0250","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CDLI.5.4.556-560.1998","article-title":"Measurement of induced cytokines in AIDS clinical trials using whole blood: a preliminary report","volume":"5","author":"Wallis","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1038\/sj.jidsymp.5650031_bb0255","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1128\/IAI.61.2.627-632.1993","article-title":"Identification by two-dimensional gel electrophoresis of a 58-kilodalton tumor necrosis factor-inducing protein of Mycobacterium tuberculosis","volume":"61","author":"Wallis","year":"1993","journal-title":"Infect Immun"},{"key":"10.1038\/sj.jidsymp.5650031_bb0260","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","article-title":"Invasive pulmonary aspergillosis associated with infliximab therapy","volume":"344","author":"Warris","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1552647X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1552647X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T21:12:11Z","timestamp":1683839531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X1552647X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0022202X1552647X"],"URL":"https:\/\/doi.org\/10.1038\/sj.jidsymp.5650031","relation":{},"ISSN":["1087-0024"],"issn-type":[{"value":"1087-0024","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}